IRCT201012031556N20已完成2 期
pioglitazone as adjuvant therapy in the treatment of major depression: a randomised and double blind study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Presence of Major Depressive Disorder based on DSM-IV criteria, Baseline Hamilton Depression Rating Scale (HAM-D) (17-item) score of at least 22. Exclusion criteria: Presence of Psychosis, any other diagnosis in Axis I and II, Receiving psychotropic medications, receiving any antidepressants during past one month or ECT during past two months, Presence of hypothyroidism or cardiovascular problems, pregnancy or nursing women
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Pilot trial studying the Effects of Pioglitazone in Comparison to Placebo on Myocardial Function and Oxidative Stress in Patients with Type II Diabetes and Insulin Resistance undergoing elective PTCAEUCTR2006-002237-20-DETakeda Pharma GmbH
终止
早期 1 期
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With GemcitabinePancreatic CancerNCT00867126University of Texas Southwestern Medical Center6
尚未招募
2 期
The effect of Rosiglitazone on negative symptoms in schizophreniaSchizophreniaIRCT20090117001556N159niversity of social welfare and rehabilitation sciences50
尚未招募
2 期
The effect of Rosiglitazone in the treatment of depressioIRCT20090117001556N152Tehran University of Medical Sciences50
终止
2 期
Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung CancerStage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung CarcinomaStage IIB Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerNCT01342770National Cancer Institute (NCI)6